v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,279,717) $ (35,041,673)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Goodwill and Intangible impairment 5,792,932 2,943,000
Stock-based compensation 417,747 80,606
Depreciation and amortization 809,731 1,076,081
Defined benefit plan obligation and other (82,877) (88,777)
Loss (gain) on disposal of property and equipment 1,385 (13,522)
Interest added to convertible note payable 0 1,164,590
Interest expense for reduction in convertible note conversion price 0 6,351,221
Amortization of debt discount and warrant modification 35,265 1,116,735
Loss on equity financing 0 15,305,761
Fair Value Adjustment of Warrants (8,584,000) (3,094,000)
Loss on debt extinguishment 125,242 1,572,512
Changes in assets and liabilities:    
Accounts receivable (1,834,573) 593,038
Inventories (160,734) 1,248,186
Prepaid expenses and other current assets 286,520 199,652
Accounts payable (1,327,451) (281,367)
Accrued liabilities and other liabilities (45,729) 185,000
Contract liabilities (112,274) (74,215)
Other 0 185,000
Net cash used in operating activities (9,958,533) (6,572,172)
CASH FLOW FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (74,658) (49,485)
Proceeds from the sale of property and equipment 0 27,510
Capitalization of internal-use software costs 0 (72,102)
Net cash used in investing activities (74,658) (94,077)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the sale of Common Stock and warrant liabilities 0 5,688,239
Payments on convertible note 0 (4,235,757)
Repayments on other short-term loan (135,000) (1,017,000)
Net cash provided by financing activities 36,204,975 9,541,626
Net change in cash 26,244,659 2,794,972
Cash at beginning of year 3,613,996 819,024
Cash at end of year 29,858,655 3,613,996
Effects of foreign exchange rates on cash flows 72,875 (80,405)
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest cash paid 35,265 2,281,325
Income taxes paid 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Amended Series B warrants reclassified to stockholders' equity (deficit) 7,766,000 0
Accrued dividends on Series F Preferred Stock 201,867 234,439
Deemed dividends on Series F and G Preferred Stock, Series B and F Warrants and warrant exchange 7,573,706 17,756,454
Accrued expense settled with Series B Warrant exercise 350,000 0
Conversion of Convertible Note Into Common Stock [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of Convertible Note 1,425,606 100,000
Conversion of Series F Preferred Stock into Common Stock [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of stock 13,089 201
Series F Warrants exchanged for shares of Common Stock 13,089 201
Conversions of Series G Preferred Stock Into Common Stock [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of stock 4,913 0
Series F Warrants exchanged for shares of Common Stock 4,913 0
Conversion of Series F Warrants to Common Stock [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of stock 89 0
Series F Warrants exchanged for shares of Common Stock 89 0
COVID Loan [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments on COVID loans (258,118) (318,793)
Series F Preferred Stock and Warrants [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the sale of preferred stock and warrants 12,800,000 4,775,000
Series G Convertible Preferred Stock [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the sale of preferred stock and warrants 11,507,350 0
Series F Convertible Preferred Stock [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 0 497,701
Issuance costs for sale of Series F preferred stock and warrants (250,578) (615,082)
Restricted Common Stock [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Stock issued 235 0
Series B Warrants [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 8,317,002 4,767,318
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Accrued expense settled with Series B Warrant exercise 350,000  
Series F Warrants [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 4,224,319  
Series A Warrants [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Stock issued $ 0 $ 6,309